ArticleNeurosurgical review2026
Multidisciplinary treatment strategy optimization and long-term prognosis in spheno-orbital meningiomas: a multicenter retrospective study.
Article in Neurosurgical review, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpheno-orbital meningiomas which includes en plaque sphenoid wing meningiomas are rare skull base tumors. Current treatment approaches include neurosurgical resection, stereotactic radiotherapy (SRT), observational follow-up, and combined modalities such as maximal safe resection with adjuvant radiotherapy/radiosurgery.
objectivesThe aim of this study was to systematically evaluate the efficacy of multidisciplinary treatment strategies, compare visual preservation and tumor control rates among different therapeutic modalities, and emphasize combined treatment paradigms for invasive cases.
methodsA multicenter retrospective study was conducted with spheno-orbital meningioma patients from January 2010-December 2021 across 3 tertiary medical centers. Patients were stratified into four groups based on initial treatment: neurosurgical resection alone, SRT alone, observational follow-up, and combined treatment such as maximal safe resection with adjuvant RT/SRS for residual tumor. Tumor subtypes were classified by anatomical involvement such as intracranial-only, hyperostosis/bone invasion, and intraorbital extension. Primary endpoints were visual function preservation and tumor control rate. Secondary endpoints included overall survival, progression-free survival (PFS), and treatment-related complications. Propensity score matching (PSM) balanced baseline confounding factors, and histological grade was incorporated into survival analyses.
resultsA total of 426 patients were included in the study and the comprised of resection alone: 218, SRT alone: 123, observation: 85, combined treatment: 47 with a median follow-up of 48 months. The resection group showed significantly higher stable/improved visual function (78.4%) compared to the SRT group (65.1%) and observation group (42.3%, p = 0.003). The combined treatment subgroup achieved an 89.4% 5-year tumor control rate and 76.6% visual preservation rate, outperforming resection alone with 88.9% tumor control, 78.4% visual preservation and SRT alone with 82.5% tumor control, 65.1% visual preservation in invasive cases.
conclusionsMultidisciplinary treatment tailored to patient-specific characteristics such as tumor location, age, volume, histological grade, and invasiveness improves outcomes in spheno-orbital meningiomas.
Indexed as
Identifiers
41896351What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.